-
Feb 2003
Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.
Arthritis RheumSteere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT -
Feb 2003
Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity.
J ImmunolHolzer U, Kwok WW, Nepom GT, Buckner JH -
Jan 2003
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells.
Clin ImmunolMaus MV, Riley JL, Kwok WW, Nepom GT, June CH -
Jan 2003
MHC multimers: expanding the clinical toolkit.
Clin ImmunolNepom GT -
Jan 2003
Challenges in staining T cells using HLA class II tetramers.
Clin ImmunolKwok WW -
Dec 2002
Therapy of autoimmune diseases: clinical trials and new biologics.
Curr Opin ImmunolNepom GT -
Dec 2002
Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes.
Inflamm ResHolmes JH 4th, Connolly NC, Paull DL, Hill ME, Guyton SW, Ziegler SF, Hall RA -
Nov 2002
Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation.
Scand J ImmunolPlesner A, Greenbaum CJ, Gaur LK, Ernst RK, Lernmark A -
Oct 2002
Use of class II tetramers for identification of CD4+ T cells.
J Immunol MethodsKwok WW, Ptacek NA, Liu AW, Buckner JH -
Sep 2002
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.
J Exp MedTatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Mueller-Berghaus J, Kirkwood JM, Kwok WW, Storkus WJ -
Sep 2002
Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
Eur J ImmunolNorrby-Teglund A, Nepom GT, Kotb M -
Sep 2002
Regulation of ionomycin-mediated granule release from rat basophil leukemia cells.
Mol ImmunolHanson DA, Ziegler SF -
Aug 2002
Type 1 diabetes intervention trials: what have we learned? A critical review of selected intervention trials.
Clin ImmunolGreenbaum CJ -
Aug 2002
Defining antigen-specific responses with human MHC class II tetramers.
J Allergy Clin ImmunolBuckner JH, Holzer U, Novak EJ, Reijonen H, Kwok WW, Nepom GT -
May 2002
Linear B-cell epitopes in Lambert-Eaton myasthenic syndrome defined by cell-free synthetic peptide binding.
J NeuroimmunolParsons KT, Kwok WW